InforCapital
Companyβ€’United Statesβ€’Updated Feb 22, 2026
Jefferson Life Sciences

Jefferson Life Sciences

Jefferson Life Sciences: Investor β€’ focus on Venture Capital β€’ active in United States β€’ offices in United States β€’ AUM $300M.

Company Profile

Jefferson Life Sciences is a privately held investment and development firm specializing in life sciences, biotechnology, and healthcare innovation. The company focuses on identifying, funding, and supporting early to mid-stage ventures that address unmet medical needs through cutting-edge research, novel therapeutics, and breakthrough technologies. Its mission is to accelerate scientific innovation from the lab to the patient, with a commitment to long-term value creation.

Operating at the intersection of science and capital, Jefferson Life Sciences provides both financial resources and strategic guidance to portfolio companies. Its team of scientific advisors, healthcare experts, and investment professionals collaborates with academic institutions, research labs, and clinical development partners to ensure rigorous evaluation and high-impact outcomes. The firm often takes an active role in shaping the growth strategy of its investments, including commercialization pathways and regulatory navigation.

With a growing presence in major biotech hubs such as Boston and San Diego, Jefferson Life Sciences maintains a global outlook, seeking opportunities that align with its mission of improving human health. The firm targets sectors such as oncology, gene therapy, rare diseases, and digital health, aiming to back solutions that not only demonstrate scientific merit but also hold the potential to transform patient care on a global scale.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.